ÅǸ޴º
¹øÈ£ | ±¸ºÐ | Á¦¸ñ |
---|---|---|
183 | (±¹¿Ü)SCI | Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: A need for surveillance |
182 | (±¹¿Ü)SCIE | Randomized controlled trial of low-volume bowel preparation agents for colonic bowel preparation: 2-L polyethylene glycol with ascorbic acid versus sodium picosulfate with magnesium citrate. |
181 | (±¹¿Ü)SCI | Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: considerations for tumor response assessment |
180 | (±¹¿Ü)SCI | Bio-sheet graft therapy for artificial gastric ulcer after endoscopic submucosal dissection: an animal feasibility study |
179 | (±¹¿Ü)SCOPUS | Cathelicidin suppresses colon cancer development by inhibition of cancer associated fibroblasts |
178 | (±¹³») ±âŸ | Extragastroesophageal Malignancy-Associated Secondary Achalasia: A Rare Association of Pancreatic Cancer Rendering Alarm Manifestation. |
177 | (±¹¿Ü)SCI | Nrf2-mediated mucoprotective and anti-inflammatory actions of Artemisia extracts led to attenuate stress related mucosal damages |
176 | (±¹¿Ü)SCIE | Nrf-mediated mucoprotective and anti-inflammatory actions of Artemisia extracts led to attenuate stress related mucosal damages. |
175 | (±¹¿Ü)SCIE | Epigenetic Mechanisms Underlying the Link between Non-Alcoholic Fatty Liver Diseases and Nutrition |
174 | (±¹¿Ü)±âŸ | Anti-fibrogenic effects of the anti-microbial peptide cathelicidin in murine colitis-associated fibrosis |
Copyright ¨Ï chamc, All rights reserved.